Effects of hydromorphone: A Synthesis of Findings from 7 Studies

  1. Home
  2. Effects of hydromorphone
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of hydromorphone: A Synthesis of Findings from 7 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of hydromorphone: A Synthesis of Findings from 7 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Hydromorphone is a medication that has been studied for its potential use in pain management in various situations, including in cancer patients. 5 investigated the effects of combining low-dose dexmedetomidine with hydromorphone for postoperative pain relief in prostate cancer patients undergoing radical prostatectomy. The study found that this combination may effectively reduce inflammation in the postoperative period. 3 compared the effects of hydromorphone and morphine in healthy volunteers and suggested that hydromorphone has a faster onset of analgesic effect and a longer duration of effect compared to morphine. 6 explored the use of hydromorphone in combination with buprenorphine in cats and indicated that hydromorphone could potentially prolong the analgesic effect when used after buprenorphine.

Benefits and Risks

Benefit Summary

Hydromorphone shows promise as a pain management medication in various situations, including in cancer patients. 5 highlighted the potential benefit of combining hydromorphone with dexmedetomidine in reducing inflammation after surgery in prostate cancer patients. 3 suggested that hydromorphone might offer a faster onset and longer duration of pain relief compared to morphine. 6 indicated that hydromorphone might be able to prolong the analgesic effect when used after buprenorphine.

Risk Summary

Hydromorphone carries the risk of side effects, such as respiratory depression. 4 suggested that adding a low basal infusion to hydromorphone-based patient-controlled intravenous analgesia (PCIA) might increase the risk of postoperative hypoxemia. 7 indicated that combining hydromorphone with the cannabinoid dronabinol may increase the risk of drug abuse.

Comparison Across Studies

Commonalities

All these studies aimed to evaluate the analgesic effects of hydromorphone. All studies suggest that hydromorphone holds potential as a valuable medication for pain management in various situations, including in cancer patients.

Differences

The studies employed different methodologies. 5 assessed postoperative pain relief in prostate cancer patients following surgery. 3 compared the analgesic effects and side effects of hydromorphone and morphine in healthy volunteers. 6 evaluated the analgesic effects of adding hydromorphone to buprenorphine in cats. 4 focused on the risk of postoperative hypoxemia associated with hydromorphone-based PCIA. 7 explored the analgesic effects and drug abuse risks of combining hydromorphone with dronabinol in healthy volunteers. 2 investigated the effect of hydromorphone on the growth of human gastric cancer cells in vitro. 1 assessed the analgesic effects of hydromorphone in great horned owls.

Consistency and Contradictions in Findings

These studies provide evidence suggesting that hydromorphone may be effective in pain management across diverse situations. However, some studies also highlight potential risks associated with its use. For instance, 4 suggested that adding a low basal infusion to hydromorphone-based PCIA might increase the risk of postoperative hypoxemia. Additionally, 7 indicated that combining hydromorphone with dronabinol may increase the risk of drug abuse.

Practical Applications and Caveats

While hydromorphone holds potential for pain management, it is crucial to remember that it can cause side effects such as respiratory depression. Therefore, it is essential to follow the instructions of your healthcare provider if you are prescribed hydromorphone. Also, it is important to note that hydromorphone has a potential for drug abuse, and its use should be approached with caution.

Limitations of Current Research

The varied methodologies employed in these studies make comparing results challenging. Furthermore, most of these studies involve relatively small sample sizes, limiting the generalizability of their findings. Further research is required to confirm and expand upon these results.

Future Research Directions

Future research should utilize larger sample sizes and employ more standardized methodologies to evaluate the effects of hydromorphone. Additionally, a more thorough assessment of the risks and benefits associated with hydromorphone is needed.

Conclusion

These studies suggest that hydromorphone may be an effective pain management medication in various situations. However, it is crucial to be aware of the potential side effects, such as respiratory depression, and the risk of drug abuse. Future research is necessary to provide a more comprehensive understanding of hydromorphone's effects and risks. Consulting with your healthcare provider is essential to make informed decisions about using hydromorphone.

Literature analysis of 7 papers
Positive Content
5
Neutral Content
1
Negative Content
1
Article Type
3
0
0
0
7
1.

Evaluation of Thermal Antinociceptive Effects of Intramuscular Hydromorphone Hydrochloride in Great Horned Owls (<i>Bubo virginianus</i>).

Author: MonopoliMarissa Rae, GuzmanDavid Sanchez-Migallon, Paul-MurphyJoanne, BeaufrèreHugues, HawkinsMichelle G

Analgesic effect
Pain management
Sedation
Tremors

This study evaluated the analgesic effect and duration of action of hydromorphone hydrochloride in great horned owls.

Randomized Controlled Trial, VeterinaryRandomized controlled trials involving animals. They evaluate the efficacy and safety of treatment methods.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

2.

Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro.

Author: LiangBeiwei, LiChunlai, ZhouZhan, XieYubo

Cancer pain treatment
Gastric cancer growth

This study aims to investigate the effects of hydromorphone, an analgesic drug, on the growth of human gastric cancer cells in vitro.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

3.

Morphine and Hydromorphone Effects, Side Effects, and Variability: A Crossover Study in Human Volunteers.

Author: MeissnerKonrad, DahanAlbert, OlofsenErik, GöpfertChristine, BloodJane, WieditzJohannes, KharaschEvan D

Analgesia
Respiratory depression

This study compared the analgesic and ventilatory effects of intravenous morphine and hydromorphone. The results suggest differences in onset, magnitude, duration, and variability of these effects between the two medications.

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

Effects of hydromorphone-based intravenous patient-controlled analgesia with and without a low basal infusion on postoperative hypoxaemia: study protocol for a randomised controlled clinical trial.

Author: MaYumei, DengZhuomin, FengXiangying, LuoJialin, MengYang, LinJingjing, MuXiaoxiao, YangXuan, NieHuang

Pain relief
Hypoxaemia
Respiratory depression

This clinical trial aims to determine if using a low basal infusion in patient-controlled intravenous analgesia (PCIA) increases the risk of postoperative hypoxemia compared to no basal infusion.

Clinical Trial ProtocolA plan for conducting a clinical trial. It describes in detail the purpose, design, methodology, and statistical considerations of the trial, ensuring the transparency and consistency of the trial.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

5.

[Effects of low-dose dexmedetomidine combined with hydromorphone in postoperative analgesia and on the serum IL-6 and CRP levels of prostate cancer patients].

Author: YangZhi-Hao, XiaXiao-Qiong, GaoXiang, YuYong-Bo, GongRen-Jie, LiYuan-Hai

Improved analgesia
Reduced inflammation

This randomized controlled trial compared the effects of low-dose dexmedetomidine combined with hydromorphone to hydromorphone alone for postoperative analgesia in prostate cancer (PCa) patients. The dexmedetomidine combination was associated with reduced pain scores and lower levels of inflammatory markers.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : Chinese

7.

Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model.

Author: DunnKelly E, BergeriaCecilia L, HuhnAndrew S, SpeedTraci J, MunChung Jung, VandreyRyan, CampbellClaudia M

Enhance analgesia
Abuse potential
Dysphoric effects

This study investigated the analgesic, abuse liability, and cognitive effects of combining hydromorphone with oral delta-9-tetrahydrocannabinol (THC; dronabinol) in healthy individuals. Only the combination of hydromorphone and low-dose dronabinol (2.5 mg) modestly enhanced analgesia, while higher doses (5 and 10 mg) increased the risk of abuse and adverse events. These findings suggest potential benefits of low-dose THC for opioid-sparing strategies but emphasize the need for caution with higher doses.

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.